Eight important updates for International HPV Awareness Day

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Today is International HPV Awareness Day.

The observance — established by International Papillomavirus Society in 2018 — is intended to increase understanding of HPV and strategies to reduce risk for HPV-related cancers.

In conjunction with International HPV Awareness Day, Healio presents the following updates in HPV prevention and research.

Several studies have provided greater insight into the effectiveness of HPV vaccines.

Source: Adobe

• One dose of the HPV vaccine appeared to be as effective as multiple doses for preventing preinvasive cervical disease among adolescents vaccinated between ages 15 and 19 years. Read more.
• High HPV vaccination coverage for girls and scaled-up screening and treatment may lead to the elimination of cervical cancer in most lower- to middle-income countries over the next 100 years, according to results of two modeling studies. Read more.
• Infections caused 13% of all new cancer diagnoses in 2018. This figure, which excludes nonmelanoma skin cancers, accounted for 2.2 million new cases worldwide. HPV was among the primary causes of these malignancies. Read more.
• Expanding the current HPV vaccination program in the United States to include men and women up to age 45 years may produce only small additional benefits and would not be nearly as cost-effective as it is for younger individuals, study results showed. Read more.
• Rates of squamous cell carcinoma of the anus and related mortality have risen sharply over the past 15 years. More than 90% of cases are associated with HPV. Read more.
• The NCI awarded a 5-year, $8.3 million research grant to fund three clinical trials that will investigate strategies to prevent HPV-related cancers among individuals with HIV. The trials will focus on oropharyngeal cancer and cervical cancer. Read more.
• Mailing HPV testing kits to women who were overdue for recommended Pap testing led to 50% more cervical cancer screenings but did not increase the detection of cervical precancer. Read more.
• HPV serotypes included in the quadrivalent vaccine decreased 86% among adolescents aged 14 to 19 years a decade after its introduction in the United States. Researchers reported a 71% decrease also occurred among those aged 20 to 24 years. Read more.